Package Leaflet: Information for the User
AIR LIQUIDE, 98.0% v/v, medicinal liquid gas in gas cylinder
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you
Keep this package leaflet, as you may need to read it again. If you have any questions, consult your doctor.
This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
If you experience side effects, consult your doctor, even if they are not listed in this package leaflet.
Contents of the package leaflet
Medicinal Nitrous Oxidebelongs to the group of general anesthetics (nervous system and central) and is an inhalation gas.
This medication is for hospital use only.
The use of this medication is indicated in the following cases:
Do not useMedicinal Nitrous Oxide:
Warnings and precautions:
Consult your doctor before starting to use Medicinal Nitrous Oxide.
Vitamin B12 levels should be evaluated in patients with risk factors for vitamin B12 deficiency before using anesthesia with nitrous oxide. Risk factors may include alcoholic patients, patients with anemia, atrophic gastritis, elderly patients, and those with a vegetarian diet or who have used medication that may interfere with vitamin B12 and/or folate metabolism. Vitamin B12 supplements should be given in case of repeated or prolonged administration.
In patients with undiagnosed subclinical vitamin B12 deficiency, neurological toxicity has occurred after a single exposure to nitrous oxide during general anesthesia.
Ear pain, and/or middle ear disorders, and/or eardrum rupture may occur in case of Eustachian tube obstruction due to increased pressure in the tympanic cavity.
Patients diagnosed with and/or at risk of intracranial hypertension should be monitored, as an increase in intracranial pressure has been observed during the administration of nitrous oxide in some patients with intracranial disorders.
Pediatric population
Rarely, nitrous oxide can cause respiratory depression in neonates. The newborn should be reviewed for possible respiratory depression when nitrous oxide is used during delivery.
Use ofMedicinal Nitrous Oxidewith other medications
Tell your doctor if you are using, have recently used, or may need to use any other medication.
Administration of nitrous oxide is contraindicated in patients with a persistent intraocular gas bubble after intraocular gas injection and/or patients who have received an intraocular gas injection in the previous 3 months, as it may cause significant vision disorders due to the expansion of the intraocular gas.
Nitrous oxide potentiates the hypnotic effects (drowsiness, sleep) of central nervous system depressant drugs (intravenous or inhaled anesthetics, tiopental, benzodiazepines, morphinics, halogenated, and psychotropics), so the dose of these should be reduced when administered at the same time.
Medications that interfere with vitamin B12 and/or folate metabolism may potentiate the inactivation of vitamin B12 by nitrous oxide.
Pregnancy and Breastfeeding
Nitrous oxide can be used during pregnancy if clinically necessary.
When nitrous oxide is used near birth, newborns should be monitored for possible adverse effects.
Nitrous oxide can be used during breastfeeding.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication.
Driving and using machines
It is recommended not to drive vehicles, not to use machines, and not to perform other psychomotor activities until you have recovered the same level of alertness as before the administration of nitrous oxide.
Medicinal Nitrous Oxide gas cylinders are intended exclusively for hospital use.
Nitrous oxide should only be administered in the operating room or delivery room, mixed with oxygen.
During pregnancy, it is recommended not to exceed a concentration of 50% nitrous oxide in the inhaled mixture.
Your doctor will determine the necessary dose of nitrous oxide, which will be administered through a system suitable for your needs, ensuring the supply of the correct amount of oxygen.
If you use moreMedicinal Nitrous Oxidethan you should
In case of overdose, there is a risk of cyanosis (bluish discoloration of the skin and mucous membranes due to lack of oxygen in the blood) and hypoxia (lack of oxygen in the blood). In these cases, the administration of nitrous oxide should be interrupted and air and oxygen should be administered to the patient.
In case of doubt, ask your doctor.
Like all medications, Medicinal Nitrous Oxidecan cause side effects, although not everyone gets them.
The possibility of presenting a side effect is described by the following categories:
Frequent (> 1/100 to < 1/10):
Gastrointestinal disorders: Nausea, vomiting.
Uncommon (> 1/1,000 to < 1/100):
Nervous system disorders: paresthesia.
Psychiatric disorders: euphoria.
Unknown (cannot be estimated from available data):
Nervous system disorders: dizziness, myelopathy, neuropathy, increased intracranial pressure, generalized seizures.
Blood and lymphatic system disorders: megaloblastic anemia, pancytopenia (observed in prone circumstances (cobalamin deficiency, substance abuse)), leukopenia/agranulocytosis (observed after very high and prolonged exposures to tetanus treatment in the 1950s).
Eye disorders: severe visual impairment (caused by the expansion of an intraocular gas).
Ear and labyrinth disorders: ear pain, middle ear disorders, eardrum rupture (in case of Eustachian tube obstruction).
Respiratory, thoracic, and mediastinal disorders: respiratory depression (in the newborn, when nitrous oxide is used during delivery).
Metabolic and nutritional disorders: vitamin B12 deficiency.
Psychiatric disorders: disorientation.
Specific to analgesia:
Uncommon (≥1/1,000 to <1/100):
Nervous system disorders: excessive sedation.
Psychiatric disorders: agitation, anxiety, hallucinations, dreams.
Unknown (cannot be estimated from available data):
Nervous system disorders: headache.
Reporting of suspected adverse reactions.
Reporting suspected adverse reactions after authorization of the medication is important. It allows for continued monitoring of the benefit/risk balance of the medication. Healthcare professionals are asked to report any suspected adverse reactions through the national reporting system: Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es
If you experience side effects, consult your doctor, even if they are not listed in this package leaflet.
Keep this medication out of the reach and sight of children.
Do not use this medication after the expiration date stated on the packaging and label. The expiration date is the last day of the month indicated.
Regarding storage and transportation, the following should be taken into account:
Storage of gas cylinders in the storage area:
Storage of gas cylinders during use:
Transportation of gas cylinders:
NOTE: Any theft or diversion of the product must be reported immediately to the authorities, the manufacturer, and the Spanish Agency for Medicines and Health Products.
Composition of Medicinal Nitrous Oxide
Appearance of the Product and Container Content
Medicinal Nitrous Oxide is packaged in gas cylinders, available in the following sizes:
A B5 cylinder contains 3.75 kg and provides 2.03 m3 of gas at a pressure of 1 bar and 15º C
A B10 cylinder contains 7.5 kg and provides 4.05 m3 of gas at a pressure of 1 bar and 15º C
A B20 cylinder contains 15.0 kg and provides 8.10 m3 of gas at a pressure of 1 bar and 15º C
A B43 cylinder contains 32.25 kg and provides 17.42 m3 of gas at a pressure of 1 bar and 15º C
A B50 cylinder contains 37.5 kg and provides 20.25 m3 of gas at a pressure of 1 bar and 15º C
Marketing Authorization Holder:
AIR LIQUIDE Santé INTERNATIONAL
75 – Quai D`Orsay
75007 – Paris (FRANCE)
Manufacturer:
Air Liquide Santé FRANCE
23 Rue d’Athènes Z.I. du Bois Briand, Nantes Cedex 03, 44336,
France
Air Liquide Healthcare España, S.L.
Polígono Industrial A Uceira, Vial 7, parcela B12-13, 32500
O Carballiño, Ourense – Spain
Date of the Last Revision of this Prospectus: April 2023
“Detailed and updated information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/”.
Instructions for Use and Handling Directed to the Healthcare Professional
Nitrous oxide is reserved for exclusive hospital use.
Medicinal Nitrous Oxide must be used exclusively mixed with Medicinal Oxygen; the oxygen concentration (FiO2) should never be less than 21%.
To avoid accidents, the following instructions will be respected:
Important:
“Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es”